Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2016, Article ID 1843201, 14 pages
http://dx.doi.org/10.1155/2016/1843201
Research Article

Tissue Kallikrein Alleviates Cerebral Ischemia-Reperfusion Injury by Activating the B2R-ERK1/2-CREB-Bcl-2 Signaling Pathway in Diabetic Rats

1Department of Neurology, Jinling Hospital, Medical School of Nanjing University, Nanjing, Jiangsu 210002, China
2Department of Neurology, Maanshan Municipal People’s Hospital, Maanshan, Anhui 243000, China
3Department of Neurology, Jinling Hospital, Southern Medical University, Nanjing, Jiangsu 210002, China
4Department of Orthopedics, Maanshan Municipal People’s Hospital, Maanshan, Anhui 243000, China
5State Key Laboratory of Organ Failure Research, National Clinical Research Center for Kidney Disease, Department of Biostatistics, School of Public Health and Tropical Medicine, Southern Medical University, 510515 Guangzhou, China

Received 23 February 2016; Accepted 6 June 2016

Academic Editor: Angel Catalá

Copyright © 2016 Ruifeng Shi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Ruifeng Shi, Kunxiong Yuan, Bin Hu, et al., “Tissue Kallikrein Alleviates Cerebral Ischemia-Reperfusion Injury by Activating the B2R-ERK1/2-CREB-Bcl-2 Signaling Pathway in Diabetic Rats,” Oxidative Medicine and Cellular Longevity, vol. 2016, Article ID 1843201, 14 pages, 2016. https://doi.org/10.1155/2016/1843201.